U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C22H26N8O5
Molecular Weight 482.4924
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 2-AMINO-N-(8-(3-(FORMYL(2-HYDROXYETHYL)AMINO)PROPOXY)-2,3-DIHYDRO-7-METHOXYIMIDAZO(1,2-C)QUINAZOLIN-5-YL)-5-PYRIMIDINECARBOXAMIDE

SMILES

COC1=C2N=C(NC(=O)C3=CN=C(N)N=C3)N4CCN=C4C2=CC=C1OCCCN(CCO)C=O

InChI

InChIKey=GBAWZLUDIKNBLK-UHFFFAOYSA-N
InChI=1S/C22H26N8O5/c1-34-18-16(35-10-2-6-29(13-32)8-9-31)4-3-15-17(18)27-22(30-7-5-24-19(15)30)28-20(33)14-11-25-21(23)26-12-14/h3-4,11-13,31H,2,5-10H2,1H3,(H2,23,25,26)(H,27,28,33)

HIDE SMILES / InChI

Approval Year

Name Type Language
2-AMINO-N-(8-(3-(FORMYL(2-HYDROXYETHYL)AMINO)PROPOXY)-2,3-DIHYDRO-7-METHOXYIMIDAZO(1,2-C)QUINAZOLIN-5-YL)-5-PYRIMIDINECARBOXAMIDE
Systematic Name English
5-PYRIMIDINECARBOXAMIDE, 2-AMINO-N-(8-(3-(FORMYL(2-HYDROXYETHYL)AMINO)PROPOXY)-2,3-DIHYDRO-7-METHOXYIMIDAZO(1,2-C)QUINAZOLIN-5-YL)-
Systematic Name English
COPANLISIB METABOLITE M21
Common Name English
Code System Code Type Description
PUBCHEM
130420805
Created by admin on Sat Dec 16 15:00:15 GMT 2023 , Edited by admin on Sat Dec 16 15:00:15 GMT 2023
PRIMARY
CAS
2132943-82-7
Created by admin on Sat Dec 16 15:00:15 GMT 2023 , Edited by admin on Sat Dec 16 15:00:15 GMT 2023
PRIMARY
FDA UNII
RTW1LKQ7TC
Created by admin on Sat Dec 16 15:00:15 GMT 2023 , Edited by admin on Sat Dec 16 15:00:15 GMT 2023
PRIMARY